Immunological biomarkers as indicators for outcome after discontinuation of nucleos(t)ide analogue therapy in patients with HB eAg‐negative chronic hepatitis B-Reference-Cited by-同舟云学术

Immunological biomarkers as indicators for outcome after discontinuation of nucleos(t)ide analogue therapy in patients with HB eAg‐negative chronic hepatitis B

Published:2019-02-27 Issue:6 Volume:26 Page:697-709
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Kranidioti Hariklia¹²,Manolakopoulos Spilios²³,Kontos George²,Breen Michael S.¹,Kourikou Anastasia²,Deutsch Melanie²,Quesada‐Del‐Bosque Maria Ester¹,Martinez‐Nunez Rocio T.¹,Naiyer Mohammed M.¹,Woelk Christopher H.¹,Sanchez‐Elsner Tilman¹,Hadziyannis Emilia³,Papatheodoridis George³^ORCID,Khakoo Salim I.¹^ORCID

Affiliation:

1. Department of Clinical and Experimental SciencesFaculty of MedicineUniversity of Southampton Southampton UK

2. 2nd Academic Department of Internal MedicineHippokration General Hospital of Athens Athens Greece

3. Academic Department of GastroenterologyLaiko General Hospital of Athens Athens Greece

Funder

Bristol-Myers Squibb

European Association for the Study of the Liver

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link